Evidence map›Paper›PMID 41741563›Full record

ArticleScientific reports2026

Deep learning framework with interpretable feature selection for accurate SUMOylation site prediction.

Aasem N Alyahya, Salman Khan, Naqqash Dilshad, Nijad Ahmad

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Aasem N AlyahyaDepartment of Computer Engineering, College of Computer and Information Sciences, King Saud University, Riyadh, 11451, Saudi Arabia.
Salman KhanDepartment of Computer Science, College of Computer and Information Sciences, King Saud University, Riyadh, 11451, Saudi Arabia.
Naqqash DilshadDepartment of Computer Science & Engineering, Sejong University, Seoul, 05006, South Korea.
Nijad AhmadDepartment of Computer Science, Khurasan University, Jalalabad, Afghanistan. nijad.khurasan@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Small ubiquitin-like modifiers (SUMOs) are crucial protein regulators influencing diverse biological processes through covalent modifications or non-covalent interactions. SUMOylation, a key post-translational modification (PTM), plays a vital role in cellular regulation. This study presents Hybrid-Sumo, a deep learning-based model integrating protein structural and sequence features to predict SUMOylation sites. Hybrid-Sumo combines three advanced feature extraction techniques: Half-Sphere Exposure (HSE), Position-Specific Scoring Matrix with Discrete Wavelet Transform (PSSM-DWT), and Bidirectional Encoder Representations from Transformers (BERT). The SHapley Additive exPlanations (SHAP) algorithm is employed for optimal feature selection, while a Deep Neural Network (DNN) serves as the classification model. Extensive 10-fold cross-validation confirms the effectiveness of Hybrid-Sumo, achieving 99.74% accuracy on benchmark datasets and 96.15% and 95.83% on balanced and imbalanced independent datasets, respectively. These results surpass existing models, improving training accuracy by 1.45% and testing accuracy (both balanced and imbalanced) by 1.90% and 0.25%, respectively. These findings highlight Hybrid-Sumo as a robust computational tool for accurate prediction of SUMOylation sites, accelerating research on protein function and modification analysis.

Indexed as

Deep LearningSmall Ubiquitin-Related Modifier ProteinsSumoylationAlgorithmsComputational BiologyHumansNeural Networks, ComputerPrediction AlgorithmsProtein Processing, Post-TranslationalSmall Ubiquitin-Related Modifier ProteinsBERTDeep learningHalf Sphere ExposureSHAPSUMOylation

Identifiers

PMID41741563
PMCPMC13031964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.